Immune System News and Research

RSS

Camouflaging of viral DNA could be crucial step in progression of cancers

An estimated 15% of cancer cases can be linked to a viral infection, however the biological changes that cause some asymptomatic carriers of a virus to develop full-blown tumors are not well understood.

9 Feb 2009

Body's defenses may worsen chronic obstructive pulmonary disorder

Although the immune system is designed to protect the body from harm, it may actually worsen one of the most difficult-to-treat respiratory diseases: chronic obstructive pulmonary disorder (COPD), according to new University of Cincinnati (UC) research.

9 Feb 2009

World experts meet in Australia to find ways to wipe out malaria

Australia is host to a meeting of World health experts which aims to find ways of eradicating malaria, one of the world's most dangerous killer diseases.

9 Feb 2009

Chemical mediator in blood found to also control breakdown of bone

A new study demonstrates that a chemical mediator in the blood that influences immune cell migration also plays a key role in maintaining the balance between the build-up and breakdown of bones in the body.

8 Feb 2009

Discovery of direct link between vitamin D and MS susceptibility 'gene'

Researchers have found evidence that a direct interaction between vitamin D and a common genetic variant alters the risk of developing multiple sclerosis (MS).

8 Feb 2009

Research to explore why lupus therapies work for some, not others

The results should shed light not only on the mechanisms behind the disease, but more broadly on the workings of our immune system, especially how our bodies churn out and "train" key combat-ready immune cells, called B-cells.

8 Feb 2009

Vitamin D linked to better muscle power

Young female athletes could have yet another reason to grab a glass of vitamin D-rich milk.

5 Feb 2009

Source of cancer stem cells' resistance to radiation discovered

Much to the dismay of patients and physicians, cancer stem cells - tiny powerhouses that generate and maintain tumor growth in many types of cancers - are relatively resistant to the ionizing radiation often used as therapy for these conditions.

5 Feb 2009

Sangamo BioSciences starts trial of CCR5-ZFP therapeutic to treat HIV/AIDS

Sangamo BioSciences, Inc. has announced that its collaborators at the University of Pennsylvania have opened a Phase 1 clinical trial to evaluate SB-728-T for the treatment of HIV/AIDS.

5 Feb 2009

Guidance for evaluating menopause-like condition in girls and young women

A comprehensive plan to help health care professionals diagnose and treat primary ovarian insufficiency-a menopause-like condition affecting girls and young women that may occur years before normal menopause is expected-has been developed by a scientist at the National Institutes of Health.

5 Feb 2009

Molecule that suppresses immune response under study in type 1 diabetes

The idea is to teach the immune system of children at high risk for type 1 diabetes not to attack the insulin-producing cells of the pancreas.

5 Feb 2009

Discovery of crucial molecule in cancer rejection

Researchers at the Centenary Institute in Sydney have discovered a molecule on the surface of immune cells which plays a critical role in cancer rejection.

5 Feb 2009

New clues to pancreatic cells' destruction in diabetes

Researchers have found what appears to be a major culprit behind the loss of insulin-producing beta cells from the pancreases of people with diabetes, a critical event in the progression of the disease.

3 Feb 2009

Scientists unlock secrets of gene regulatory networks

A quartet of studies by researchers at the California Institute of Technology (Caltech) highlight a special feature on gene regulatory networks recently published in the Proceedings of the National Academy of Sciences ( PNAS ).

3 Feb 2009

Stat3 signaling tips the balance of immunity in favor of cancer

New research reveals how a cancer-associated protein enables tumor cells to evade the immune system by both suppressing antitumor influences and promoting tumor-enhancing conditions, in essence turning the immune system to the dark side of the force.

2 Feb 2009

Quinolone-resistant gonorrhea increases in Ontario

The prevalence of quinolone-resistant gonorrhea has increased rapidly in Ontario - Canada's most populous province - from a rate of 2% in 2001 to 28% in 2006, found a study published in CMAJ.

2 Feb 2009

New potential targets for colitis-associated cancer

Recent research from the laboratory of Michael Karin, PhD, at the University of California, San Diego School of Medicine - the first researcher to demonstrate a molecular link between inflammation and cancer - has identified two potential targets for the prevention and treatment of colitis-associated cancer (CAC), the most serious complication of inflammatory bowel disease.

2 Feb 2009